Computational Competitive and Negative Design To Derive a Specific cJun Antagonist.

Area of Science:

• Molecular Biology
• Biochemistry
• Computational Biology

Background:

• Basic leucine zipper (bZIP) proteins regulate gene transcription and are crucial in cellular processes.
• Activator protein-1 (AP-1) dimers, particularly involving c-Jun, are implicated in diseases like cancer and psoriasis.
• Targeting disease-associated bZIP proteins is a key therapeutic goal.

Purpose of the Study:

• To develop a novel in silico screening platform for identifying high-affinity c-Jun binding peptides.
• To design peptides that selectively inhibit c-Jun activity while avoiding homodimerization or binding to related proteins like c-Fos.
• To validate the computational approach through in vitro assessment.

Main Methods:

• Computational screening of a large peptide library (>60 million members) using a Fos template.
• Ranking of potential peptide-target interactions based on predicted complex stability.
• Selection and characterization of a lead peptide sequence for c-Jun interaction.

Main Results:

• Identification of a novel peptide sequence with high affinity for c-Jun.
• The selected peptide demonstrated low homomeric stability and minimal binding to c-Fos.
• The computationally derived peptide exhibited comparable interaction stability to previously known antagonists but with enhanced specificity.

Conclusions:

• The study demonstrates the efficacy of a tandem in silico screening and in vitro validation approach.
• This method enables the design of peptides with high specificity for disease-relevant targets like c-Jun.
• The findings offer a promising strategy for developing targeted peptide therapeutics for diseases involving bZIP proteins.